We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

100 hedge funds and large institutions have $445M invested in Stemline Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 56 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 18

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

4% more funds holding

Funds holding: 96 → 100 (+4)

20% less capital invested

Capital invested by funds: $555M → $445M (-$110M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

69% less call options, than puts

Call options by funds: $292K | Put options by funds: $932K

Holders
100
Holders Change
+4
Holders Change %
+4.17%
% of All Funds
2.19%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
17
Increased
56
Reduced
18
Closed
13
Calls
$292K
Puts
$932K
Net Calls
-$640K
Net Calls Change
+$860K

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$20.5M
2
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$20M
3
EAM
Eventide Asset Management
Massachusetts
+$12.7M
4
FCM
Farallon Capital Management
California
+$10.5M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$8.05M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.62M
2
SSA
Schonfeld Strategic Advisors
New York
-$6.86M
3
Citadel Advisors
Citadel Advisors
Florida
-$4.52M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.94M
5
FI
Fosun International
China
-$3.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Clearline Capital
New York
$3.19M +$2.03M +154,924 +102%
Charles Schwab
27
Charles Schwab
California
$2.87M +$2.37M +181,200 +193%
Prudential Financial
28
Prudential Financial
New Jersey
$2.82M +$628K +48,010 +23%
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$2.26M -$3.94M -301,370 -58%
CC
30
Carlson Capital
Texas
$2.01M -$2.69M -205,400 -52%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.9M +$272K +20,760 +13%
T. Rowe Price Associates
32
T. Rowe Price Associates
Maryland
$1.84M -$7.62M -582,570 -77%
UBS Group
33
UBS Group
Switzerland
$1.67M +$1.07M +82,154 +105%
N
34
Nuveen
North Carolina
$1.54M +$251K +19,223 +15%
PVI
35
Pura Vida Investments
New York
$1.38M -$277K -21,176 -14%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$1.23M +$472K +36,082 +44%
CS
37
Candriam SCA
Luxembourg
$1.19M +$445K +34,000 +43%
DMK
38
David M. Knott
$1.12M +$95.5K +7,300 +7%
LCM
39
Laurion Capital Management
New York
$1.04M +$1.31M +100,000 New
BFM
40
Boothbay Fund Management
New York
$959K +$59.2K +4,525 +5%
Swiss National Bank
41
Swiss National Bank
Switzerland
$860K +$238K +18,200 +28%
Wells Fargo
42
Wells Fargo
California
$744K +$115K +8,786 +14%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$727K +$107K +8,164 +13%
Victory Capital Management
44
Victory Capital Management
Texas
$712K +$873K +66,753 +4,149%
SSA
45
Schonfeld Strategic Advisors
New York
$691K -$6.86M -524,000 -89%
Citigroup
46
Citigroup
New York
$636K +$617K +47,193 +340%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$626K +$58.9K +4,500 +8%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$612K +$184K +14,051 +31%
OAM
49
Oxford Asset Management
United Kingdom
$597K +$750K +57,346 New
Neuberger Berman Group
50
Neuberger Berman Group
New York
$585K -$520K -39,772 -41%
1
2
3 4 5

STML Hedge Fund Activity: Q3 2019 in Review

100 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q3 2019, worth a combined $445M — down 20% from $555M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new STML positions and 13 closed out — a net gain of 4 holders — while 56 added to existing stakes and 18 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $20.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $7.62M.

  • 100 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q3 2019, up from 96 in Q2 2019.
  • Funds reported $445M of Stemline Therapeutics, Inc. stock for Q3 2019, down 20% quarter-over-quarter.
  • 17 funds opened new Stemline Therapeutics, Inc. positions in Q3 2019 and 13 closed out, a net change of +4 holders.
  • The largest Stemline Therapeutics, Inc. buyer in Q3 2019 was AllianceBernstein, an estimated $20.5M added.
  • The largest Stemline Therapeutics, Inc. seller in Q3 2019 was T. Rowe Price Associates, an estimated $7.62M sold.

Based on aggregated 13F filings for Q3 2019.